Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Phytomedicine ; 39: 137-145, 2018 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-29433675

RESUMO

BACKGROUND: Cytochrome P450 2J2 (CYP2J2) is not only highly expressed in many kinds of human tumors, but also promotes tumor cell growth via regulating the metabolism of arachidonic acids. CYP2J2 inhibitors can significantly reduce proliferation, migration and promote apoptosis of tumor cells by inhibiting epoxyeicosatrienoic acids (EETs) biosynthesis. Therefore screening CYP2J2 inhibitors is a significant way for the development of anti-cancer drug. PURPOSE: The aim of this study was to identify a new CYP2J2 inhibitor from fifty natural compounds obtained from plants. STUDY DESIGN: CYP2J2 inhibitor was screened from a natural compounds library and further the inhibitory manner and mechanism were evaluated. Its cytotoxicity against HepG2 and SMMC-7721 cell lines was also estimated. METHODS: The inhibitory effect was evaluated in rat liver microsomes (RLMs), human liver microsomes (HLMs) and recombinant CYP2J2 (rCYP2J2), using astemizole as a probe substrate and inhibitory mechanism was illustrated through molecular docking. The cytotoxicity was detected using SRB. RESULTS: In all candidates, plumbagin showed the strongest inhibitory effect on the CYP2J2-mediated astemizole O-demethylation activity. Further study revealed that plumbagin potently inhibited CYP2J2 activity with IC50 value at 3.82 µM, 3.37 µM and 1.17 µM in RLMs, HLMs and rCYP2J2, respectively. Enzyme kinetic studies showed that plumbagin was a mixed-type inhibitor of CYP2J2 in HLMs and rCYP2J2 with Ki value of 1.88 µM and 0.92 µM, respectively. Docking data presented that plumbagin interacted with CYP2J2 mainly through GLU 222 and ALA 223. Moreover, plumbagin showed strongly cytotoxic effects on hepatoma cell lines, such as HepG2 and SMMC-7721, with lower toxicity on rat primary hepatocytes. Plumbagin had no effect on the protein expression of CYP2J2 in HepG2 and SMMC-7721, while down-regulated the mRNA level of anti-apoptosis protein Bcl-2. CONCLUSION: This study found out a new CYP2J2 inhibitor plumbagin from fifty natural compounds. Plumbagin presented a potential of anti-cancer pharmacological activity.


Assuntos
Inibidores das Enzimas do Citocromo P-450/farmacologia , Sistema Enzimático do Citocromo P-450/química , Sistema Enzimático do Citocromo P-450/metabolismo , Naftoquinonas/farmacologia , Animais , Antineoplásicos/farmacologia , Produtos Biológicos/farmacologia , Carcinoma Hepatocelular/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Citocromo P-450 CYP2J2 , Inibidores das Enzimas do Citocromo P-450/química , Avaliação Pré-Clínica de Medicamentos/métodos , Hepatócitos/efeitos dos fármacos , Humanos , Cinética , Neoplasias Hepáticas/tratamento farmacológico , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Simulação de Acoplamento Molecular , Naftoquinonas/química , Ratos Sprague-Dawley
2.
Sci Rep ; 7: 42922, 2017 02 20.
Artigo em Inglês | MEDLINE | ID: mdl-28218310

RESUMO

Cytochrome P450 (CYP) 3A accounts for nearly 30% of the total CYP enzymes in the human liver and participates in the metabolism of over 50% of clinical drugs. Moreover, CYP3A plays an important role in chemical metabolism, toxicity, and carcinogenicity. New animal models are needed to investigate CYP3A functions, especially for drug metabolism. In this report, Cyp3a1/2 double knockout (KO) rats were generated by CRISPR-Cas9 technology, and then were characterized for viability and physiological status. The Cyp3a1/2 double KO rats were viable and fertile, and had no obvious physiological abnormities. Compared with the wild-type (WT) rat, Cyp3a1/2 expression was completely absent in the liver of the KO rat. In vitro and in vivo metabolic studies of the CYP3A1/2 substrates indicated that CYP3A1/2 was functionally inactive in double KO rats. The Cyp3a1/2 double KO rat model was successfully generated and characterized. The Cyp3a1/2 KO rats are a novel rodent animal model that will be a powerful tool for the study of the physiological and pharmacological roles of CYP3A, especially in drug and chemical metabolism in vivo.


Assuntos
Sistemas CRISPR-Cas/genética , Citocromo P-450 CYP3A/genética , Animais , Citocromo P-450 CYP3A/deficiência , Feminino , Genótipo , Meia-Vida , Intestino Delgado/metabolismo , Intestino Delgado/patologia , Fígado/metabolismo , Fígado/patologia , Masculino , Microssomos Hepáticos/metabolismo , Nifedipino/análise , Nifedipino/metabolismo , Nifedipino/farmacocinética , Fenótipo , Isoformas de Proteínas/metabolismo , Ratos , Ratos Sprague-Dawley
3.
Zhongguo Yi Liao Qi Xie Za Zhi ; 32(4): 249-52, 2008 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-18973032

RESUMO

Factors influencing the temperature-sensing accuracy of an ablation catheter are analyzed, in this paper, from the two aspects of the thermocouple temperature sensor, which are the TC length and the TC hole's diameter of the ablation electrode. Meanwhile, differences between products from different companies are given too.


Assuntos
Ablação por Cateter/métodos , Temperatura , Eletrodos
4.
Zhongguo Yi Liao Qi Xie Za Zhi ; 32(1): 29-31, 2008 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-18438047

RESUMO

An electrolytically-detachable microcoil is introduced here in the paper. The testing results indicate that, the microcoils have stable mechanical properties, clear radiographic images and fine insulation performance. Their detaching time varies from 30s to 200s when voltage changes from 2V to 5V.


Assuntos
Embolização Terapêutica/instrumentação , Aneurisma Intracraniano/terapia , Desenho de Equipamento
5.
Zhongguo Yi Liao Qi Xie Za Zhi ; 32(5): 373-6, 2008 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-19119661

RESUMO

This essay is to make brief comments on the Nitinol vascular stents fatigue lifetime requirements, finite element analysis and fatigue lifetime tests etc.


Assuntos
Prótese Vascular , Análise de Elementos Finitos , Teste de Materiais , Ligas , Stents
6.
Zhongguo Yi Liao Qi Xie Za Zhi ; 31(6): 433-8, 2007 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-18269044

RESUMO

With the development of cerebral interventional medical devices, Nitinol alloy has been widely used in clinical fields as a good biomaterial. This essay is to make brief comments on Nitinol alloy's present development, its material characteristics, medical basic researches, and applications in cerebral interventional devices.


Assuntos
Ligas , Materiais Biocompatíveis , Revascularização Cerebral/instrumentação , Stents , Humanos
7.
Zhongguo Yi Liao Qi Xie Za Zhi ; 29(6): 391-5, 2005 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-16494046

RESUMO

This essay is to make brief comments on the physical characteristics, biocompatibility, corrosion resistance, clinical information, existent problems of endovascular stent biomaterials and the developing tendency in future.


Assuntos
Angioplastia/instrumentação , Materiais Biocompatíveis , Stents
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA